Search

Your search keyword '"Tokgözoǧlu, Lale"' showing total 94 results

Search Constraints

Start Over You searched for: Author "Tokgözoǧlu, Lale" Remove constraint Author: "Tokgözoǧlu, Lale"
94 results on '"Tokgözoǧlu, Lale"'

Search Results

1. Association of BMI, lipid-lowering medication, and age with prevalence of type 2 diabetes in adults with heterozygous familial hypercholesterolaemia: a worldwide cross-sectional study

2. Addressing residual risk beyond statin therapy: New targets in the management of dyslipidaemias–A report from the European Society of Cardiology Cardiovascular Round Table

4. Diet, Lifestyle, Smoking

6. Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

10. 2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk

11. Clinical management, psychosocial characteristics, and quality of life in patients with homozygous familial hypercholesterolemia undergoing LDL-apheresis in Turkey: Results of a nationwide survey (A-HIT1 registry)

14. What have we learned from Turkish familial hypercholesterolemia registries (A-HIT1 and A-HIT2)?

16. Editor's Choice – 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS)

17. A nation-wide survey of patients with homozygous familial hypercholesterolemia phenotype undergoing LDL-apheresis in Turkey (A-HIT 1 registry)

18. Guía ESC 2021 sobre la prevención de la enfermedad cardiovascular en la práctica clínica: Con la contribución especial de la European Association of Preventive Cardiology (EAPC)

20. Women, lipids, and atherosclerotic cardiovascular disease:a call to action from the European Atherosclerosis Society

21. 2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia:New treatments and clinical guidance

22. 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias: The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)

26. 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias

27. Corrigendum to “2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk” [Atherosclerosis 290 (2019) 140–205]

28. Erratum to “2019 ESC/EAS guidelines for the management of dyslipidemias: Lipid modification to reduce cardiovascular risk” [Atherosclerosis 290 (2019) 140–205]

31. The spoils of war and the long-term spoiling of health conditions of entire nations

34. Low-density lipoproteins cause atherosclerotic cardiovascular disease.1. Evidence from genetic, epidemiologic, and clinical studies:. A consensus statement fromthe European Atherosclerosis Society Consensus Panel

Catalog

Books, media, physical & digital resources